Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

4.2K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
Bone Remodeling01:40

Bone Remodeling

41.0K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.0K
Bone Disorders01:29

Bone Disorders

7.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.4K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.7K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

6.0K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
6.0K
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

9.3K
9.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pathogenesis and intersecting mechanisms of monogenic bone mass disorders.

Nature reviews. Endocrinology·2026
Same author

Melanocortin 3 Receptors Do Not Specifically Localize to Primary Cilia in Cultured Human and Rodent Neurons.

Cell biochemistry and function·2026
Same author

<i>QKI</i> dysregulation induces extensive splicing changes in T-cell acute lymphoblastic leukemia.

Haematologica·2026
Same author

The Paraoxonase (<i>PON</i>) Gene Family in Health, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Other Diseases.

International journal of molecular sciences·2025
Same author

The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture.

Expert opinion on drug discovery·2025
Same author

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration.

Clinical epigenetics·2025

Related Experiment Video

Updated: Mar 27, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K

Genetic control of bone mass.

Eveline Boudin1, Igor Fijalkowski1, Gretl Hendrickx1

  • 1Department of Medical Genetics, University of Antwerp, Antwerp, Belgium.

Molecular and Cellular Endocrinology
|January 10, 2016
PubMed
Summary

Genetic factors significantly influence bone mineral density (BMD), impacting osteoporosis risk. This review explores monogenic bone disorders and genetic influences on normal BMD variation.

Keywords:
Bone mineral densityGeneticsOsteogenesis imperfectaOsteoporosisPaget's disease of boneSclerosing bone dysplasias

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K
Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.1K

Related Experiment Videos

Last Updated: Mar 27, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K
Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.1K

Area of Science:

  • Genetics
  • Bone Biology
  • Metabolic Disorders

Background:

  • Bone mineral density (BMD) is crucial for diagnosing osteoporosis, a condition marked by reduced bone mass and increased fracture risk.
  • While environmental factors play a role, heritability studies indicate 50-85% of BMD variation is genetically controlled, often polygenically.
  • Monogenic bone disorders, caused by single gene mutations, can lead to extremely high or low BMD.

Purpose of the Study:

  • To review the genetic causes of monogenic bone disorders with abnormal BMD.
  • To summarize current knowledge on genetic factors influencing normal BMD variation and osteoporosis susceptibility.
  • To highlight key signaling pathways and therapeutic targets in BMD regulation.

Main Methods:

  • Review of literature on monogenic bone disorders and genetic regulation of BMD.
  • Analysis of genetic studies including linkage, candidate gene, and genome-wide association studies (GWAS).
  • Discussion of emerging approaches like rare variant analysis, copy number variations, and epigenetics.

Main Results:

  • Identification of genes causing monogenic bone disorders has advanced understanding of BMD regulation.
  • Key pathways (e.g., involving sclerostin, RANKL, cathepsin K) are implicated in both rare disorders and normal BMD variation.
  • Despite technological advances, a significant portion of genetic influence on BMD remains unexplained ('missing heritability').

Conclusions:

  • Genetic factors are central to BMD regulation and osteoporosis risk.
  • Further research into rare variants, CNVs, and epigenetics is needed to explain the full genetic contribution to BMD.
  • Understanding these genetic underpinnings is vital for developing novel therapeutic strategies for bone disorders.